Found 32 matching trials
Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT PHASE1 The purposes of the study are to determine the maximum tolerated dose (MTD)...
Show More Status
Active Not Recruiting
Location
Moffitt Cancer Center
Learn More & Join Trial
Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab N/A This is a non-interventional cohort study evaluating non-relapse mortality ...
Show More Learn More & Join Trial
Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events N/A Prospective determination of the clinical utility of measurable residual di...
Show More Learn More & Join Trial
Pilot Study of Etoposide-based Therapy and Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis NA The investigators would like to propose a pilot study evaluating the effica...
Show More Location
Asan Medical center, University of Ulsan College of Medicine
Learn More & Join Trial
Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome PHASE1 This phase I studies the side effects and best dose of total marrow and lym...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories NA This is a two-arm pilot randomized trial that assesses the feasibility and ...
Show More Location
University of Rochester
Learn More & Join Trial
CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease PHASE2 This phase II trial studies the effect of CPX-351 followed by donor stem ce...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ... PHASE1 Background:
People living with HIV(PLWH) are at a higher risk for cancers ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant PHASE1 This phase I trial tests the safety, side effects, best dose and effectiven...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation NA This is a single center pilot study evaluating intraoral photobiomodulation...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial